We are live on
!
Find out more
AstraZeneca
AZN
AZN
379 hedge funds and large institutions have $7.87B invested in AstraZeneca in 2013 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 131 increasing their positions, 125 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
178% more call options, than puts
Call options by funds: $191M | Put options by funds: $68.6M
158% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 26
15% more capital invested
Capital invested by funds: $6.87B → $7.87B (+$1.01B)
10% more funds holding
Funds holding: 343 → 379 (+36)
5% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 125
0.03% less ownership
Funds ownership: 10.47% → 10.44% (-0.03%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
379
Holders Change
+36
Holders Change %
+10.5%
% of All Funds
11%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.23%
New
67
Increased
131
Reduced
125
Closed
26
Calls
$191M
Puts
$68.6M
Net Calls
+$122M
Net Calls Change
+$32.1M
Top Buyers
Top Sellers
| 1 |
U
UBS
Zurich,
Switzerland
|
-$143M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$125M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$66.5M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$60.8M |
| 5 |
Two Sigma Investments
New York
|
-$49.4M |
